Xvivo Perfusion AB (publ) (LON:0RKL)

Market Cap	1.07B
Revenue (ttm)	59.36M
Net Income (ttm)	12.43M
Shares Out	n/a
EPS (ttm)	0.39
PE Ratio	86.38
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	115
Average Volume	1,885
Open	458.00
Previous Close	463.34
Day's Range	458.00 - 459.50
52-Week Range	205.50 - 459.50
Beta	2.09
RSI	47.65
Earnings Date	Jan 27, 2025

About Xvivo Perfusion AB

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden, the United States, the Netherlands, Italy, North and South America, Europe, the Middle East, Africa, the Asia Pacific, and Oceania. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a c...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1998
• Employees: 170
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RKL

Financial Performance

In 2024, Xvivo Perfusion AB's revenue was 822.42 million, an increase of 37.63% compared to the previous year's 597.54 million. Earnings were 172.18 million, an increase of 87.52%.

Financial numbers in SEK